Cell 2026 brings together bioprocessing specialists, advanced therapy developers and CGT manufacturing leaders across three connected programmes in London, 12–13 November. From cell line...

Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse drug delivery challenges. Visitors to stand...

Leading African biopharmaceutical company Minapharm Group, headquartered in Egypt with subsidiaries in Berlin, will receive up to US$16.5 million from the Coalition for Epidemic Preparedness...

NRG, an innovative clinical stage neuroscience company targeting a novel mechanism to restore mitochondrial dysfunction in neurodegenerative diseases, today presented a poster on preclinical...

VarmX, a biotech company developing innovative approaches to bypass direct oral anticoagulants targeting activated factor Xa (FXa inhibitors), enrolled the first participant in its global phase 3...

Aurora Cannabis, the Canadian-based leading global medical cannabis company, has acquired Internode Pharma, a licensed importer and wholesaler and HAP Pharma, a licensed pharmacy. Strategic rationale • The UK...

FairJourney Bio, a global antibody discovery expert, has announced the publication of a peer-reviewed study in mAbs describing a novel approach with the potential to...

CPHI & PMEC Shenzhen 2026 is set to welcome its most international audience to date, reflecting growing global interest in South China's rapidly evolving pharmaceutical market...

Fujifilm’s commercial-scale cell culture manufacturing facility in Holly Springs, North Carolina, has been selected as one of only seven participants in the US Food...

Taysha Gene Therapies, a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for rare, monogenic diseases of the central nervous system,...